Navigation Links
Voices Against Brain Cancer Discusses How Minimally Invasive Brain Surgery is Helping Brain Cancer Patient Beat the Odds
Date:12/28/2013

New York, NY (PRWEB) December 28, 2013

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, responds to an article published by KFor.com on December 17th, which discusses a new treatment that is giving hope to brain tumor patients because of its proven success.

According to the December 17th article published by KFor.com titled “New treatment giving hope to cancer patients with brain tumors,” Bonnie Naifeh, a brain cancer patient, received an early Christmas miracle after learning she was tumor free. She was initially diagnosed with a brain tumor after visiting her eye surgeon back in 2007. Since then, the tumor has resurfaced multiple times.

After the third diagnosis, her doctor Dr. Michael Sughrue with OU Medical Center gave Bonnie three options. She could do nothing, go through radiation or have brain surgery. Naifeh decided to have an endoscopic pituitary gland surgery.

Endoscopic pituitary gland surgery is an approach that is much less invasive, using a camera to go up the nasal cavity and removing the tumor through the nose. This gives doctors a full view of the brain tumor in comparison to more standard methods that give surgeons a much narrower view. The process “decreases the threat that the tumors will return and also provides a faster recovery.”

Michael Klipper, Chairman of Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, is happy to hear of Bonnie’s success story. “Oftentimes, when discussing this awful disease, all you hear are devastating numbers and statistics,” he says. “However, Bonnie’s story provides the rest of the brain cancer community with a glimmer of hope that there are other treatment options being developed that not only will get us closer to finding a cure but provide a much better quality of life as well.”

VABC has a wide variety of initiatives in place for brain cancer research, awareness and support. The organization’s research grants fund cutting-edge research programs that will have a monumental impact on the diagnosis and treatment of brain cancer. VABC currently funds research at several esteemed institutions such as Brookhaven National Laboratory, Cleveland Clinic, Columbia, Cornell, Duke, Harvard, Johns Hopkins, Memorial Sloan-Kettering and Yale, to name a few.

VABC's mission is to find a cure for brain cancer by advancing scientific research, increasing awareness within the medical community and supporting patients, their families and caregivers afflicted with this devastating disease.

For press inquiries, please contact: http://www.5wpr.com.
#####

Read the full story at http://www.prweb.com/releases/2013/12/prweb11445836.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Voices Against Brain Cancer Discusses New Brain Tumor Vaccine HSPPC-96
2. Voices Against Brain Cancer Hosts Contest on Facebook to Recognize Neurosurgeons and Nurses
3. Voices Against Brain Cancer Commends Baseball Coach’s Perseverance to Live a Full Life
4. National Voices for Equality, Education and Enlightenment (NVEEE) to Host 3rd Annual “Not on My Watch” VIP Reception Benefiting Bullying and Suicide Prevention Efforts
5. A New Website for Families to Turn: New Health and Wellness Promotion Website Launched by Family Voices
6. Voices Against Brain Cancer Commends 18-Year-Old Brain Cancer Patient for His Positive Outlook and Will to Live
7. Voices Against Brain Cancer to Host Annual “Join the Voices! Run/Walk” in Partnership with New York Road Runners
8. Voices Against Brain Cancer Commends Tech Startup Co-Founder for Positive Outlook Despite Grim Diagnosis
9. Voices Against Brain Cancer Commends Researchers for the Identification of an Important Protein that May Give Insight to More Effective Glioblastoma Treatments
10. Voices Against Brain Cancer Comments On Breakthrough Brain Surgery Technique
11. Redressing Past Wrongs: Changing the Common Rule to Increase Minority Voices in Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... ... March 01, 2017 , ... ... permanently embedded anti-odor solution to cotton knit and woven fabrics. , Retail ... maintaining the luxurious look and feel of cotton. Cotton Incorporated has developed ...
(Date:3/1/2017)... HILLS, CA (PRWEB) , ... March 01, 2017 , ... ... cryoablation for the treatment of early stage breast cancer and where it fits in ... Genes & The Choices We Make .” The event brings together leading cancer and ...
(Date:3/1/2017)... ... March 01, 2017 , ... Expert on international living and leading a ... & Go. , Time & Go app is the ultimate strategic compass that helps ... time management methods enable people to work smarter, not harder, that's why Time & ...
(Date:3/1/2017)... York, NY & Greenwich, CT (PRWEB) , ... March 01, 2017 ... ... many runners, especially in the winter months when people don’t want to stop training ... the knees – and setting the treadmill to a small incline can help protect ...
(Date:3/1/2017)... ... March 01, 2017 , ... “McFarnia”: a suspenseful tale of ... truth about his life and mysterious disappearance. “McFarnia” is the creation of published author ... North Carolina. He currently serves as a Chaplain with Transport for Christ at a ...
Breaking Medicine News(10 mins):
(Date:3/1/2017)... Calif. , March 1, 2017   Sun Chlorella ... about all things chlorella, is pleased to announce Non-GMO Project ... premium chlorella powder. Just in time for the ... in Anaheim, CA , Sun Chlorella Corp. ... all chlorella products, including: Sun Chlorella ...
(Date:3/1/2017)... 2017  Integrated Modular Design (IMD), a ... implementation of pre-fabricated healthcare products like bathroom ... seeks to lead the construction industry toward ... Fueled by their leading-edge pre-fabrication solutions, ... construction timelines and project risk, and increasing ...
(Date:3/1/2017)... 1, 2017  Global biotherapeutics leader CSL Behring ... ever Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) trial, known as ... reatment with H izentra ® ).  The Phase ... safety and tolerability of two different doses of CSL ... Subcutaneous [Human]), compared with placebo, in the maintenance treatment ...
Breaking Medicine Technology: